Life sciences organizations call for collaboration across government to improve outcomes for patients

October 4, 2021

Canadians look to the 44th Parliament to […]

Innovative Medicines Canada congratulates Prime Minister Justin Trudeau on his re-election

September 21, 2021

IMC welcomes Canada’s 44th Parliament […]

New fellowship in health systems resilience opens call for applicants

August 19, 2021

The HRF launched its Fellowship in Health Systems Resilience […]

IMC supports national Biomanufacturing and Life Sciences Strategy commitment to ensuring best-in-class regulation

July 28, 2021

Today, Innovation, Science and Economic Development Canada […]

PMPRB delay provides opportunity for meaningful consultation

June 29, 2021

IMC views Health Canada’s decision to delay implementation […]

PMPRB risks harming the health of Canadians by reducing access to new medicines

June 23, 2021

On June 21, IMC submitted six recommendations […]

Put Canadians first by suspending the implementation of harmful drug pricing regulations

June 4, 2021

IMC calls on the federal government to suspend […]

Innovative Medicines Canada cautions against COVID-19 TRIPS IP waiver

May 6, 2021

Ottawa, May 6, 2021—The extraordinary development of the COVID-19 vaccines now being deployed globally is a testament to collaboration and innovation by governments, industry, and other stakeholders. Waiving TRIPS Intellectual […]

IMC welcomes investments in life sciences sector, but more collaboration needed

April 19, 2021

IMC welcomes the federal government’s acknowledgment in Budget 2021 […]

New Statistics Canada research shows the full extent of the innovative pharmaceutical sector’s investments in Canada

April 12, 2021

Statistics Canada’s new report […]